Markets

AbCellera To Present Phase 2 Data On ABCL635 At IMS 20th World Congress On Menopause

Sep 16, 2026 · 04:08 PM ET· updated 2h ago

AbCellera (NASDAQ:ABCL) today announced an upcoming oral presentation of Phase 2 data on ABCL635 at the International Menopause Society (IMS) 20th World Congress on Menopause, to be held September 30 to October 3, 2026

Why It Matters

AbCellera will show early test results for a menopause medicine at a big conference. When companies share medicine data publicly, watch if doctors and patients react well to it.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

ABCL11.68

+0.27 (+2.32%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.